Stockholders’ Deficiency - Accounting allocation of initial proceeds (Details) (USD $)	1 Months Ended	3 Months Ended
	Jan. 31, 2014 Series E Convertible Preferred Stock	Oct. 31, 2014 Series E Convertible Preferred Stock	Oct. 31, 2014 Series F Convertible Preferred Stock	Mar. 27, 2014 Series F Convertible Preferred Stock
Net proceeds	$ 750,000	$ 750,000	$ 2,020,000	$ 2,020,000
Derivative warrant liability fair value		(942,279)	(2,016,064)
Derivative additional investment rights fair value			(863,735)
Other issuance costs (finders' fee)		(64,000)	(166,000)
Make whole payments liability		(216,000)	(560,250)
Deemed dividend		$ (472,279)	$ (1,586,050)